> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-222/
- Published: 2019-05-05T12:00:00.000Z
- Updated: 2026-09-15T01:24:38.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144037

[**Priority Voucher Redeemed for Alexion’s Ultomiris**](https://www.fdaweb.com/priority-voucher-redeemed-for-alexions-ultomiris-2/)  
*Federal Register* notice: FDA announces the approval of product that redeemed a priority review voucher — Alexion Pharmaceuticals’ Ultomiris (ravulizumab-cwvz). 05/03/2019

[**Update to Susceptibility Test Interpretive Criteria Page**](https://www.fdaweb.com/update-to-susceptibility-test-interpretive-criteria-page/)  
*Federal Register* notice: FDA has made available its annual compilation of updates to the Susceptibility Test Interpretive Criteria Web page. 05/03/2019

[**Patient Preference-Sensitive Priorities**](https://www.fdaweb.com/patient-preference-sensitive-priorities/)  
*Federal Register* notice: FDA makes available a list of patient preference-sensitive priorities on FDA’s Web site entitled “Patient Preference-Sensitive Areas: Using Patient Preference Information in Medical Device Evaluation.” 05/03/2019

[**International Cosmetics Regulation Meeting**](https://www.fdaweb.com/international-cosmetics-regulation-meeting/)  
*Federal Register* notice: FDA announces a 6/5 public meeting entitled “International Cooperation on Cosmetics Regulation (ICCR) — Preparation for ICCR-13 Meeting.” 05/02/2019

[**Info Collection Extension for Mammography Requirements**](https://www.fdaweb.com/info-collection-extension-for-mammography-requirements/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for “Mammography Quality Standards Act Requirements — 21 CFR Part 900.” 05/01/2019

[**Workshop on Adenoviral Infection Drug Development**](https://www.fdaweb.com/workshop-on-adenoviral-infection-drug-development/)  
*Federal Register* notice: FDA announces an 8/8 public workshop entitled “Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients.” 05/01/2019

[**Info Collection on Xenotransplant Infectious Disease Guide**](https://www.fdaweb.com/info-collection-on-xenotransplant-infectious-disease-guide/)  
*Federal Register* notice: FDA submits to OMB an information collection extension for “Public Health Service Guideline on Infectious Disease Issues in Xenotransplantation.” 04/30/2019

[**Info Collection on Device Detention**](https://www.fdaweb.com/info-collection-on-device-detention/)  
*Federal Register* notice: FDA sends to OMB an information collection extension for “Administrative Detention and Banned Medical Devices — 21 CFR 800.55(g)(1), (g)(2), and (k), 895.21(d), and 895.229(a).” 04/29/2019